PRDX2 and mantle cell lymphoma: To analyze if PRDX2 was involved in drug resistance, as reported for other tumors24,30,31, we next evaluated the response of our MCL cell line models to drugs strongly dependent on ROS-induced cytotoxicity, like doxorubicin and vincristine.